Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
11/2012
11/01/2012WO2012149358A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
11/01/2012US20120277291 Preventive for adhesion following abdominal surgery
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276160 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012US20120276158 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276080 Sheet-like composition
10/2012
10/31/2012CN102755327A Application of asiatic acid or salt thereof and injection suspension and preparation method thereof
10/25/2012US20120270878 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120263733 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012138212A1 Food composition for intra-operative tube feeding
10/10/2012CN102716281A Care solution for cleaning wounds after operation
10/10/2012CN102716073A Medical carboxymethyl chitosan anti-adhesion agent and preparation method thereof
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012133295A1 Bioabsorbable antiadhesive material containing contrast medium
10/04/2012US20120252779 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/03/2012CN102698129A Traditional Chinese medicine composition for treating postoperative intestinal adhesion
09/2012
09/26/2012EP2501361A1 Method for treating retinal conditions using an intraocular tamponade
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/19/2012EP2498805A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding
09/12/2012CN102665733A Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
09/12/2012CN102657850A Sustained-release tissue engineering membrane loaded with transforming growth factor beta 3 (TGF-beta3)
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263068 Modified cells expressing a protein that modulates activity of bHLH proteins, and uses thereof
09/11/2012CA2446374C Surgical wound closure system
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/05/2012CN102652835A Sustained-release polymer retinoic acid
09/05/2012CN102028706B Flushing liquid for liver-cancer surgical incisions
09/05/2012CN101513439B Notoginseng sodium hyaluronate gel for preventing from adhesion after spine laminectomy
08/2012
08/29/2012CN1889974B Oligopeptides as coating material for medical products
08/29/2012CN102430034B Medicine composition for enhancing wound healing after cesarean section and applications
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120213798 Methods and uses for treating hepatic ischemia and reperfusion injury
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/16/2012WO2012108831A1 Metabotropic glutamate receptor group i antagonists for treatment of abnormal union of tissue
08/16/2012US20120207745 Composition to Induce Specific Immune Tolerance
08/15/2012EP2485739A1 Methods and compositions for maintenance of a functional wound
08/15/2012CN102631712A Application of medical silicone oil as medicament for treating lacrimal duct obstruction disease
08/15/2012CN101203251B 玻璃体可视化剂 Vitreous visualization agent
08/09/2012US20120201890 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells
08/08/2012CN101935363B Method for producing pharmaceutical grade hyaluronic acid
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195972 Ophthalmic formulations and uses thereof
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012CA2825512A1 Radiopaque embolic particles
07/2012
07/26/2012WO2012100050A1 A composition for the attachment of implants to collagen or other components of biological tissue
07/26/2012US20120190003 Organ arrest, protection, preservation and recovery
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189584 Genipin cross-linked fibrin gels
07/26/2012US20120189583 Placental or umbilical cord tissue compositions
07/25/2012CN102604916A Induction of gene expression using a high concentration sugar mixture
07/19/2012US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/18/2012CN102178691B Starch stypticum and preparation method thereof
07/17/2012US8221758 Anti-midkine antibody for preventing post-laparotomy adhesions
07/12/2012US20120178787 Melatonin and its use in preventing postoperative complications
07/12/2012US20120177645 Methods and compositions for the inhibition of transplant rejection
07/11/2012EP2474569A1 Porous structure
07/11/2012CN102552120A Surgical anti-adhesion flushing liquid
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/04/2012EP2471360A1 Improved tissue maintenance
07/04/2012CN102526796A Absorbable haemostatic material prepared based on rat tail collagen and preparation method of same
07/04/2012CN101675061B Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
06/2012
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120164115 Methods related to surgery
06/27/2012CN102512573A Nursing liquid for promoting wound healing
06/21/2012US20120158114 Cochlear implant drug delivery device
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/20/2012EP1857544B1 Pluripotent stem cell derived from cardiac tissue
06/14/2012US20120148668 Intracoronary device and method of use thereof
06/13/2012CN102488908A Flushing fluid for electrocision and application of same
06/07/2012WO2012072374A1 Priming solutions for cardiopulmonary bypass
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141415 Albumin Fusion Proteins
06/06/2012EP2459200A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
05/2012
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2495350C Use of lck inhibitor for treatment of immunologic diseases
05/24/2012US20120129954 Carboxymethylcellulose polyethylene glycol compositions for medical uses
05/23/2012EP1499329B2 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
05/23/2012CN102138979B Pharmaceutical composition for preventing and treating intestinal adhesion after abdominal operation
05/23/2012CN102018868B Allium macrostemon preparation for preventing intestinal adhesions and preparation method thereof
05/23/2012CN101822643B Ligustrazine nanoparticle, preparation method and pharmaceutical application thereof
05/23/2012CN101721423B Bicarbonate physiological balanced solution and preparation method thereof
05/17/2012US20120121686 Biodegradable compositions having pressure sensitive adhesive properties
05/16/2012CN102459351A 多糖类衍生物及其水凝胶 Polysaccharide derivatives and hydrogels
05/15/2012US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178499 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/10/2012WO2012021818A3 Ggf2 and methods of use
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 38